LifeVantage Announces Intent to Launch Protandim Nrf1 Synergizer Product
February 19 2016 - 2:20PM
Company to expand Protandim product line to include
Nrf1 and Nrf2 Synergizer products that work synergistically to
naturally reduce cellular stress
LifeVantage Corporation (Nasdaq:LFVN), has announced its intent to
launch Protandim Nrf1 Synergizer moments ago during its Elite
Academy in Nashville, TN. The company intends to host a live
cyber-launch in the fourth quarter of fiscal 2016 that will
broadcast worldwide through the company’s website.
“We will continue to strategically introduce new products that
align with our objective to have a cohesive product offering that
is unique and exclusive to LifeVantage, and provides optimal health
for everyone,” said LifeVantage President and Chief Executive
Officer, Darren Jensen. “The Protandim NFR1 Synergizer is
formulated to strengthen the mitochondria, which are the power
house of all cells for better cellular health. It is designed to
work in tandem with our flagship Protandim Nrf2 Synergizer product
and further enhance our body’s ability to naturally produce
antioxidants and reduce the effects of cellular stress on its own.”
Jensen continues, “Our advances in Nrf1 and Nrf2 Synergizer science
continues to position LifeVantage on the leading-edge of
Nutrigenomics.”
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN), is a science based
network marketing company dedicated to visionary science that looks
to transform health, wellness and anti-aging internally and
externally at the cellular level. The company is the maker of
Protandim®, the Nrf2 Synergizer® patented dietary supplement, the
TrueScience™ Anti-Aging Skin Care Regimen, Canine Health, the AXIO™
energy product line and the PhysIQ™ smart weight management system.
LifeVantage was founded in 2003 and is headquartered in Salt Lake
City, Utah.
Forward Looking Statements
This document contains forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Words and expressions reflecting optimism,
satisfaction or disappointment with current prospects, as well as
words such as "believe", "hopes", "intends", "estimates",
"expects", "projects", "plans", "anticipates", "look forward to",
“goal”, “ideal fit”, and variations thereof, identify
forward-looking statements, but their absence does not mean that a
statement is not forward-looking. Examples of forward-looking
statements include, but are not limited to, statements we make
regarding our leadership in the global market, future growth and
financial performance. Such forward-looking statements are not
guarantees of performance and the Company's actual results could
differ materially from those contained in such statements. These
forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that
may cause the Company's actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks
and uncertainties include, among others, those discussed in greater
detail in the Company's Annual Report on Form 10-K and the
Company's Quarterly Report on Form 10-Q under the caption "Risk
Factors," and in other documents filed by the Company from time to
time with the Securities and Exchange Commission. The Company
cautions investors not to place undue reliance on the
forward-looking statements contained in this document. All
forward-looking statements are based on information currently
available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of
this document, except as required by law.
Company Relations Contact:
John Genna (801) 432-9172
Vice President of Communications
& Corporate Partnerships
Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
-or-
John Mills (646) 277-1254
Partner, ICR INC
-or-
Scott Van Winkle (617) 956-6736
Managing Director, ICR INC
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Sep 2023 to Sep 2024